Chiome Bioscience Inc. (TYO:4583)
Japan
· Delayed Price · Currency is JPY 134.00
+1.00 (0.75%)
May 2, 2025, 3:30 PM JST
Chiome Bioscience Cash Flow Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -1,021 | -1,220 | -1,243 | -1,480 | -1,294 | Upgrade
|
| Depreciation & Amortization | 1.17 | 1.2 | 1.48 | 2.96 | 3.7 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | 150 | - | Upgrade
|
| Other Operating Activities | -32.46 | 7.05 | 22.69 | 22.15 | -31.68 | Upgrade
|
| Change in Accounts Receivable | 32.13 | 32.02 | -89.76 | 31.32 | 38.36 | Upgrade
|
| Change in Inventory | 17.94 | 7.37 | -12.49 | 30.21 | -22.64 | Upgrade
|
| Change in Accounts Payable | -10.54 | 5.87 | 2.06 | -10.3 | 10.17 | Upgrade
|
| Change in Unearned Revenue | - | - | -4.6 | - | - | Upgrade
|
| Change in Other Net Operating Assets | 11.88 | 97.31 | 132.49 | 122.27 | -64.26 | Upgrade
|
| Operating Cash Flow | -1,001 | -1,069 | -1,191 | -1,131 | -1,360 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.17 | - | - | - | Upgrade
|
| Other Investing Activities | - | - | - | -35.38 | -3.52 | Upgrade
|
| Investing Cash Flow | - | 0.17 | - | -35.38 | -3.52 | Upgrade
|
| Short-Term Debt Issued | - | 107 | 1 | 3 | 180 | Upgrade
|
| Total Debt Issued | - | 107 | 1 | 3 | 180 | Upgrade
|
| Short-Term Debt Repaid | -9.5 | - | - | - | - | Upgrade
|
| Total Debt Repaid | -9.5 | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -9.5 | 107 | 1 | 3 | 180 | Upgrade
|
| Issuance of Common Stock | 1,748 | 560.3 | 1,126 | 268.34 | 1,770 | Upgrade
|
| Repurchase of Common Stock | -0.58 | - | - | - | - | Upgrade
|
| Other Financing Activities | -0 | 0 | -0 | 0 | -5.94 | Upgrade
|
| Financing Cash Flow | 1,738 | 667.3 | 1,127 | 271.35 | 1,944 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | -0 | Upgrade
|
| Net Cash Flow | 737.73 | -401.72 | -63.72 | -895.33 | 580.34 | Upgrade
|
| Free Cash Flow | -1,001 | -1,069 | -1,191 | -1,131 | -1,360 | Upgrade
|
| Free Cash Flow Margin | -128.16% | -156.67% | -188.81% | -158.68% | -282.86% | Upgrade
|
| Free Cash Flow Per Share | -17.19 | -21.58 | -27.08 | -28.09 | -37.91 | Upgrade
|
| Cash Interest Paid | 2.87 | 2.07 | 1.32 | 1.32 | 0.97 | Upgrade
|
| Cash Income Tax Paid | 5.01 | 5.01 | 3.24 | -4.56 | 2.42 | Upgrade
|
| Levered Free Cash Flow | -651.57 | -630.68 | -748.1 | -648.68 | -888.73 | Upgrade
|
| Unlevered Free Cash Flow | -649.78 | -629.39 | -747.27 | -647.86 | -888.13 | Upgrade
|
| Change in Net Working Capital | 6.66 | -122.64 | -37.91 | -183.13 | 89.57 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.